| 2806 |
388: Overactivation, NMDARs |
2078: Loss of drebrin |
Dec 11, 2022 |
Jul 17, 2024 |
None
|
| 3038 |
388: Overactivation, NMDARs |
1527: Increase, Cell membrane depolarization |
Sep 14, 2023 |
Sep 14, 2023 |
1 AOP
|
| 3068 |
388: Overactivation, NMDARs |
12: AchE Inhibition |
Oct 17, 2023 |
Oct 17, 2023 |
1 AOP
|
| 3069 |
388: Overactivation, NMDARs |
618: Decreased, Neuronal network function in adult brain |
Oct 17, 2023 |
Oct 17, 2023 |
1 AOP
|
| 3071 |
388: Overactivation, NMDARs |
188: Neuroinflammation |
Oct 17, 2023 |
Oct 17, 2023 |
1 AOP
|
| 2404 |
1886: Overexpression of rasl11b |
1821: Decrease, Cell proliferation |
May 28, 2021 |
Dec 12, 2021 |
1 AOP
|
| 661 |
664: Overwhelmed, Mitochondrial DNA repair mechanisms |
570: Accumulation, Damaged mitochondrial DNA |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1852 |
1596: Oxidation of DNA |
1599: Inflammatory events |
Feb 4, 2019 |
Feb 4, 2019 |
None
|
| 1850 |
1594: Oxidation of membrane lipids |
1599: Inflammatory events |
Feb 4, 2019 |
Jul 9, 2019 |
1 AOP
|
| 954 |
926: Oxidation, Glutathione |
927: S-Glutathionylation, eNOS |
Nov 29, 2016 |
Sep 28, 2017 |
None
|
| 2459 |
926: Oxidation, Glutathione |
1115: Increase, ROS |
Aug 5, 2021 |
Aug 5, 2021 |
1 AOP
|
| 864 |
844: Oxidation, Uroporphyrinogen |
846: Accumulation, Highly carboxylated porphyrins |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 865 |
844: Oxidation, Uroporphyrinogen |
845: Inhibition, UROD |
Nov 29, 2016 |
May 30, 2018 |
1 AOP
|
| 1851 |
1595: Oxidation/denatuation of membrane proteins |
1599: Inflammatory events |
Feb 4, 2019 |
Jul 9, 2019 |
1 AOP
|
| 1669 |
1477: OXPHOS, decreased |
40: Mitochondrial ATP production, decreased |
Oct 10, 2017 |
Oct 10, 2017 |
2 AOPs
|
| 1810 |
1477: OXPHOS, decreased |
1562: Decreased Na/K ATPase activity |
Dec 20, 2018 |
Dec 20, 2018 |
1 AOP
|
| 2095 |
1477: OXPHOS, decreased |
1771: Decrease, ATP pool |
Apr 30, 2020 |
Apr 30, 2020 |
1 AOP
|
| 2346 |
1477: OXPHOS, decreased |
1808: Decrease, ATP synthase activity |
Apr 11, 2021 |
Apr 11, 2021 |
None
|
| 2713 |
1477: OXPHOS, decreased |
1392: Increase, Oxidative Stress |
Jul 25, 2022 |
Jul 25, 2022 |
None
|
| 1282 |
1231: Oxidization of biomolecules, Lipid bilayer and cellular proteins |
1215: TRPA1 activation, TRPA1 Receptor |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1285 |
1231: Oxidization of biomolecules, Lipid bilayer and cellular proteins |
1236: Generation of novel epitopes , Antigen presentation |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1286 |
1231: Oxidization of biomolecules, Lipid bilayer and cellular proteins |
1234: Production of nerve growth factor , Epithelial irritation |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1711 |
1504: p21 (CDKN1A) expression, increase |
1505: Cell cycle, disrupted |
Jan 21, 2018 |
Jul 25, 2018 |
None
|
| 3083 |
896: Parkinsonian motor deficits |
350: Increase, Mortality |
Oct 17, 2023 |
Oct 17, 2023 |
1 AOP
|
| 236 |
209: Peptide Oxidation |
134: Increase, Kupffer cell activation |
Nov 29, 2016 |
Dec 3, 2016 |
None
|